KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biolife Solutions (BLFS) Shares Outstanding (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Shares Outstanding for 16 consecutive years, with $48.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2.75% to $48.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.2 million through Dec 2025, up 2.75% year-over-year, with the annual reading at $48.2 million for FY2025, 2.75% up from the prior year.
  • Shares Outstanding for Q4 2025 was $48.2 million at Biolife Solutions, roughly flat from $48.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $48.2 million in Q4 2025, with the low at $33.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $44.1 million, with a median of $43.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding soared 56.11% in 2021, then rose 2.13% in 2023.
  • Over 5 years, Shares Outstanding stood at $41.8 million in 2021, then increased by 2.43% to $42.8 million in 2022, then grew by 5.45% to $45.2 million in 2023, then grew by 3.85% to $46.9 million in 2024, then rose by 2.75% to $48.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $48.2 million, $48.0 million, and $47.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.